Psychopharmacologic Treatment of Aggression in Children and Adolescents

Pediatric Annals

Volumn 33, Issue 5, 2004, Pages 318-327

  Ruths, Steven ^a,c   Steiner, Hans ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c MC 5018 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CARBAMAZEPINE; CITALOPRAM; CLONIDINE; CLOZAPINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; HALOPERIDOL; LITHIUM; METHYLPHENIDATE; NEUROLEPTIC AGENT; NON PRESCRIPTION DRUG; NORFLUOXETINE; OLANZAPINE; PAROXETINE; PSYCHOSTIMULANT AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; UNINDEXED DRUG; VALPROATE SEMISODIUM; ZIPRASIDONE;

ACNE; AGGRESSION; AGRANULOCYTOSIS; ALGORITHM; ANXIETY DISORDER; APLASTIC ANEMIA; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BIPOLAR DISORDER; BLEEDING; BLOOD DYSCRASIA; BRAIN INJURY; CHILD BEHAVIOR; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COMA; CONDUCT DISORDER; CONSTIPATION; CRISIS INTERVENTION; DIABETES INSIPIDUS; DIABETES MELLITUS; DIARRHEA; DIZZINESS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DYSTONIA; ERYTHEMA MULTIFORME; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEPATITIS; HUMAN; HYPERLIPIDEMIA; HYPERPROLACTINEMIA; HYPERSALIVATION; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INSOMNIA; LETHARGY; LEUKOCYTOSIS; LIVER TOXICITY; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL HEALTH; META ANALYSIS; METABOLIC SYNDROME X; NEUROLEPTIC MALIGNANT SYNDROME; ORTHOSTATIC HYPOTENSION; OVARY POLYCYSTIC DISEASE; PANCREATITIS; PARKINSONISM; PHENOTYPE; POLYDIPSIA; POLYURIA; POSTTRAUMATIC STRESS DISORDER; PSYCHOPHARMACOTHERAPY; QT PROLONGATION; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; STEVENS JOHNSON SYNDROME; SYSTEMATIC REVIEW; TARDIVE DYSKINESIA; THROMBOCYTOPENIA; THYROID DISEASE; TORSADE DES POINTES; TREATMENT INDICATION; TREATMENT OUTCOME; TREMOR; URINE RETENTION; VISUAL IMPAIRMENT; WEIGHT GAIN;

EID: 2442493934     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20040501-10     Document Type: Review

References (42)

1. Steiner H. Disruptive behavior disorders. In: Kaplan HI, Sadock BJ, eds. Kaplan & Sadock's Comprehensive Textbook of Psychiatry. Vol 2. 7th ed. New York, NY: Lippincott Williams & Wilkins Publishers; 2000:2693-2703.
2. Barkley RA, Mash EJ, eds. Child Psychopathology. 2nd ed. New York, NY: Guilford Press; 2002.
3. Steiner H, Saxena K, Chang K. Psychopharmacologic strategies for the treatment of aggression in juveniles. CNS Spectr. 2003:8(4):298-308.
4. Masters KJ, Bellonci C, Bemet W, et al. Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions, with special reference to seclusion and restraint. J Am Acad Child Adolesc Psychiatry. 2002;41(2 Suppl):4S-25S.
5. Connor DF. Aggression and Antisocial Behavior in Children and Adolescents. New York, NY: Guilford Press; 2002.
6. Steiner H, Saxena K, Chang K. Psychopharmacologic strategies for the treatment of aggression in juveniles. CNS Spectr. 2003:8(4):298-308.
7. Vitiello B, Stoff DM. Subtypes of aggression and their relevance to child psychiatry. J Am Acad Child Adolesc Psychiatry. 1997;36(3): 307-315.
8. Connor DF, Glatt SJ, Lopez ID, Jackson D, Melloni RH. Psychopharmacology and aggression. I: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry. 2002;41(3):253-261.
9. Bauer MS, Mitchner L. What is a "mood stabilizer"? An evidence-based response. Am J Psychiatry. 2004;161(1):3-18.
10. Campbell M, Small AM, Green WH, et al. Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry. 1984;41(7):650-656.
11. Malone RP, Delaney MA, Luebbert JF, Cater J, Campbell M. A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Arch Gen Psychiatry. 2000;57(7):649-654.
12. Donovan SJ, Stewart JW, Nunes EV, et al. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. Am J Psychiatry. 2000;157(5):818-820.
13. Steiner H, Petersen M, Saxena K, Ford S, Matthews Z. Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial. J Clin Psychiatry. 2003;64(10):1183-1191.
14. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(4 Suppl):1-50.
15. Cueva JE, Overall JE, Small AM, et al. Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 1996;35(4):480-490.
16. McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347(5):314-321.
17. Buitelaar JK, van der Gaag RJ, Cohen-Kettenis P, Melman CT. A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry. 2001;62(4):239-248.
18. Findling RL, McNamara NK, Branicky LA, et al. A double-blind pilot study of risperidone in the treatment of conduct disorder. J Am Acad Child Adolesc Psychiatry. 2000;39(4):509-516.
19. Findling RL, Kusumakar V, Daneman D, et al. Prolactin levels during long-term risperidone treatment in children and adolescents. J Clin Psychiatry. 2003;64(11):1362-1369.
20. Glazer WM, Dickson RA. Clozapine reduces violence and persistent aggression in schizophrenia. J Clin Psychiatry. 1998;59(Suppl 3):8-14.
21. Schur SB, Sikich L, Findling RL, et al. Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I. J Am Acad Child Adolesc Psychiatry. 2003;42(2):132-144.
22. Pappadopulos E, Macintyre Ii JC, Crismon ML, et al. Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. J Am Acad Child Adolesc Psychiatry. 2003;42(2):145-161.
23. Klein RG, Abikoff H, Klass E, et al. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry. 1997;54(12):1073-1080.
24. Brown GL, Ebert MH, Goyer PF, et al. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry. 1982;139(6):741-746.
25. Kruesi MJ, Rapoport JL, Hamburger S. Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Gen Psychiatry. 1990;47(5):419-426.
26. Armenteros JL, Lewis JE. Citalopram treatment for impulsive aggression in children and adolescents: an open pilot study. J Am Acad Child Adolesc Psychiatry. 2002;41(5):522-529.
27. Hazell PL, Stuart JE. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad Child Adolesc Psychiatry. 2003;42(8):886-894.
28. Kemph JP, DeVane CL, Levin GM, Jarecke R, Miller RL. Treatment of aggressive children with clonidine: results of an open pilot study. J Am Acad Child Adolesc Psychiatry. 1993;32(3):577-581.
29. King BH, Wright DM, Snape M, Dourish CT. Case series: amantadine open-label treatment of impulsive and aggressive behavior in hospitalized children with developmental disabilities. J Am Acad Child Adolesc Psychiatry. 2001;40(6):654-657.
30. Cherek DR, Lane SD, Pietras CJ, Sharon J, Steinberg JL. Acute effects of baclofen, a gamma-aminobutyric acid-B agonist, on laboratory measures of aggressive and escape responses of adult male parolees with and without a history of conduct disorder. Psychopharmacology (Berl). 2002;164(2):160-167.
31. Connor DF, Ozbayrak KR, Benjamin S, Ma Y, Fletcher KE. A pilot study of nadolol for overt aggression in developmentally delayed individuals. J Am Acad Child Adolesc Psychiatry. 1997;36(6):826-834.
32. Coccaro EF, Gabriel S, Siever LJ. Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans. Psychopharmacol Bull. 1990;26(3):393-405.
33. Cherek DR, Moeller FG, Khan-Dawood F, Swann A, Lane SD. Prolactin response to buspirone was reduced in violent compared to non-violent parolees. Psychopharmocology (Berl). 1999;142(2):144-148.
34. Pande AC, Crockatt J, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord. 2000;2(3 Pt 2):249-255.
35. Frye MA, Ketter TA, Kimbrell TA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol. 2000;20(6): 607-614.
36. Tallian KB, Nahata MC, Lo W, Tsao CY. Gabapentin associated with aggressive behavior in pediatric patients with seizures. Epilepsia. 1996;37(5):501-502.
37. Pachet A, Friesen S, Winkelaar D, Gray S. Beneficial behavioral effects of lamotrigine in traumatic brain injury. Brain Inj. 2003;17(8):715-722.
38. Beran RG, Gibson RJ. Aggressive behavior in intellectually challenged patients with epilepsy treated with lamotrigine. Epilepsia. 1998;39(3):280-282.
39. Elwes RD, Binnie CD. Clinical pharmacokinetics of newer antiepileptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarbazepine. Clin Pharmacokinet. 1996;30(6): 403-415.
40. Kaufman KR, Kugler SL, Sachdeo RC. Tiagabine in the management of postencephalitic epilepsy and impulse control disorder. Epilepsy Behav. 2002:3(2):190-194.
41. Zubieta JK, Alessi NE. Acute and chronic administration of trazodone in the treatement of disruptive behavior disorders in children. J Clin Psychophamwcol. 1992;12(5):346-351.
42. Fugate LP, Spacek LA, Kresty LA, et al. Measurement and treatment of agitation following traumatic brain injury: II. A survey of the Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation. Arch Phys Med Rehabil. 1997;78(9):924-928.